Presentationer och intervjuer

BioStock interview with WntResearch’s CEO Pernilla Sandwall, 28 september 2022

VD Pernilla Sandwall presenterar bolaget på Biostock Investor Meeting, 14 september 2022

VD Pernilla Sandwall intervjuas av Biostock, 18 augusti 2022

Presentation Aktiespararnas Småbolagsdagar 13 juni, 2022

Presentation Biostock Life Science Spring Summit 9 juni, 2022

Informationsmöte i anslutning till årsstämman 2 juni 2022

Company presentation, March 2022

Presentation med frågor på Aktiespararnas aktiekväll, video

Presentationsbilder från Aktiespararnas aktiekväll

14 april, 2021

Intervju med Anders Rabbe i Biostocks studio

14 april, 2021

VD Anders Rabbes presentation på Biostock live

12 april, 2021

Mangold Insights Investerarfrukost

7 april, 2021

Investerarpresentation april 2021

Se presentation

Investerarpresentation mars 2021

Se presentation

VD Peter Morsing presenterar på Aktiespararnas digitala arrangemang

4 maj 2020


Tommy Andersson på Mangold Insights investerardag

15 november 2019

VD Peter Morsing presenterar på Stora Aktiedagen i Göteborg

4 november 2019


Tommy Andersson på Öresundsdagen

20 maj, 2019

”Sitdown” intervju med vd Peter Morsing

27 februari 2019


WntResearch presenterar på Stockholm Corporate Finance Life Science Seminarium

7 mars 2018


Informationsmaterial som t.f. vd Ulf Björklund presenterade vid den extra bolagsstämman

20 september 2017


Presentation vid Stockholm Corporate Finance Life Science Seminarium

22 mars 2017


Presentation vid Investor Dagen i Köpenhamn

21 mars 2017


Presentation vid Biotech Showcase i San Francisco 

11 januari 2017  



Aktiespararna Stockholm Vasa och Financial Stockholm

25 oktober kl. 18:00


Aktiespararna, Malmö Centrum

May 11th, 2016

Interview with CEO Henrik Lawaetz

March 16th, 2016


Sedermeradagen, Lund

March 16th, 2016

Stockholm Corporate Finance, Stockholm

March 10th, 2016

Video from presentation of WntResearch at Stockholm Corporate Finance

CEO Henrik Lawaetz and CSO Tommy Andersson presented the company  at Stockholm Corporate Finance Life Science & Healthcare Seminar at Operaterrassen in Stockholm Thursday March 10th.


LifeScienceDagen 2016, Göteborg.

 March 9th, 2016

A commentary on the interim Foxy-5 phase 1 study report

The recent publication of an interim report of Foxy-5 clinical Phase 1 study has raised a lot of questions. This has prompted us to write a clarification on how WntResearch values the results obtained so far.


Short congress report 

From AACR.NCI.EORTC Scientific meeting: Molecular Targets and Cancer Therapeutics in cancer, November 5-9, 2015 in Boston, USA with comments from CEO Nils Brünner


Foxy-5 – Preliminary Report: Phase I

Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of Foxy-5 in Patients with Metastatic Breast, Colon or Prostate Cancer
November 6th, 2015


WntResearch at Sedermeradagen in Lund 26 March 2015

Speaker: Nils Brünner, VD


Annual General Assembly, Malmø, 09.06.15

Speaker: Nils Brünner, CEO